Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release

Virology

Volumn 464-465, Issue 1, 2014, Pages 111-117

  Masrinoul, Promsin ^a   Puiprom, Orapim ^a   Tanaka, Atsushi ^b   Kuwahara, Miwa ^a,b   Chaichana, Panjaporn ^a   Ikuta, Kazuyoshi ^b   Ramasoota, Pongrama ^c   Okabayashi, Tamaki ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b OSAKA UNIVERSITY   (Japan)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chikungunya virus; Monoclonal antibody; Post entry inhibitory step

Indexed keywords

CHIKUNGUNYA VIRUS ENVELOPE 1 PROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ARTICLE; CHIKUNGUNYA ALPHAVIRUS; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN DOMAIN; PROTEIN TARGETING; VIRUS ENTRY; VIRUS RELEASE; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; CHIKUNGUNYA FEVER; DRUG EFFECTS; FEMALE; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION; VIRUS RELEASE;

EID: 84904874174     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.05.038     Document Type: Article

References (35)

1. Burt F.J., Rolph M.S., Rulli N.E., Mahalingam S., Heise M.T. Chikungunya: a re-emerging virus. Lancet 2012, 379(9816):662-671.
2. Charrel R.N., de Lamballerie X., Raoult D. Chikungunya outbreaks the globalization of vector borne diseases. N. Engl. J. Med. 2007, 356(8):769-771.
3. Couderc T., Khandoudi N., Grandadam M., Visse C., Gangneux N., Bagot S., Prost J.F., Lecuit M. Prophylaxis and therapy for chikungunya virus infection. J. Infect. Dis. 2009, 200(4):516-523.
4. Dowdle W.R., Downie J.C., Laver W.G. Inhibition of virus release by antibodies to surface antigens of influenza viruses. J. Virol. 1974, 2:269-275.
5. Fric J., Bertin-Maghit S., Wang C.I., Nardin A., Warter L. Use of human monoclonal antibodies to treat chikungunya virus infection. J. Infect. Dis. 2013, 207(2):319-322.
6. Garoff H., Sjöberg M., Cheng R.H. Budding of alphaviruses. Virus Res. 2004, 106(2):103-116.
7. Jose J., Snyder J.E., Kuhn R.J. A structural and functional perspective of alphavirus replication and assembly. Future Microbiol. 2009, 7:837-856.
8. Fields W., Kielian M. A key interaction between the alphavirus envelope proteins responsible for initial dimer dissociation during fusion. J. Virol. 2013, 7:3774-3781.
9. Kajihara M., Marzi A., Nakayama E., Noda T., Kuroda M., Manzoor R., Matsuno K., Feldmann H., Yoshida R., Kawaoka Y., Takada A. Inhibition of marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein. J. Virol. 2012, 86(24):13467-13474.
10. Kail M., Hollinshead M., Ansorge W., Pepperkok R., Frank R., Griffiths G., Vaux D. The cytoplasmic domain of alphavirus E2 glycoprotein contains a short linear recognition signal required for viral budding. EMBO J. 1991, 9:2343-2351.
11. Kanai Y., Chittaganpitch M., Nakamura I., Li G.M., Bai G.R., Li Y.G., Ikuta K., Sawanpanyalert P. Distinct propagation efficiencies of H5N1 influenza virus Thai isolates in newly established murine respiratory region-derived cell clones. Virus Res. 2010, 153(2):218-225.
12. Kielian M. Structural biology: an alphavirus puzzle solved. Nature 2010, 468(7324):645-646.
13. Lee C.Y., Kam Y.W., Fric J., Malleret B., Koh E.G., Prakash C., Huang W., Lee W.W., Lin C., Lin R.T., Renia L., Wang C.I., Ng L.F., Warter L. Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants. PLoS Pathog. 2011, 12:e1002390.
14. Li L., Jose J., Xiang Y., Kuhn R.J., Rossmann M.G. Structural changes of envelope proteins during alphavirus fusion. Nature 2010, 468(7324):705-708.
15. Lim C.K., Nishibori T., Watanabe K., Ito M., Kotaki A., Tanaka K., Kurane I., Takasaki T. Chikungunya virus isolated from a returnee to Japan from Sri Lanka: isolation of two sub-strains with different characteristics. Am. J. Trop. Med. Hyg. 2009, 81(5):865-868.
16. Lum F.M., Teo T.H., Lee W.W., Kam Y.W., Rénia L., Ng L.F. An essential role of antibodies in the control of Chikungunya virus infection. J Immunol. 2013, 190(12):6295-6302. (2013).
17. Masrinoul P., Diata M.O., Pambudi S., Limkittikul K., Ikuta K., Kurosu T. Highly conserved region 141-168 of the NS1 protein is a new common epitope region of dengue virus. Jpn. J. Infect. Dis. 2011, 64(2):109-115.
18. Noda M., Masrinoul P., Punkum C., Pipattanaboon C., Ramasoota P., Setthapramote C., Sasaki T., Sasayama M., Yamashita A., Kurosu T., Ikuta K., Okabayashi T. Limited cross-reactivity of mouse monoclonal antibodies against dengue virus capsid protein among four serotypes. Biologics 2012, 6:409-416.
19. Okabayashi T., Kariwa H., Yokota S., Iki S., Indoh T., Yokosawa N., Takashima I., Tsutsumi H., Fujii N. Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J. Med. Virol. 2006, 78(4):417-424.
20. Orvell C., Kristensson K. The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of sendai virus from infected cells. Arch. Virol. 1985, 86(1-2):1-15.
21. Pal P., Dowd K.A., Brien J.D., Edeling M.A., Gorlatov S., Johnson S., Lee I., Akahata W., Nabel G.J., Richter M.K., Smit J.M., Fremont D.H., Pierson T.C., Heise M.T., Diamond M.S. Development of a highly protective combination monoclonal antibody therapy against chikungunya virus. PLoS Pathog. 2013, 9(4):e1003312.
22. Pialoux G., Gaüzère B.A., Jauréguiberry S., Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis. 2007, 7(5):319-327.
23. Puiprom O., Morales Vargas R.E., Potiwat R., Chaichana P., Ikuta K., Ramasoota P., Okabayashi T. Characterization of chikungunya virus infection of a human keratinocyte cell line: role of mosquito salivary gland protein in suppressing the host immune response. Infect. Genet. Evol. 2013, 17:210-215.
24. Reading S.A., Dimmock N.J. Neutralization of animal virus infectivity by antibody. Arch. Virol. 2007, 152(6):1047-1059.
25. Robinson M.C. An epidemic of virus disease in Southern Province, Tanganyika Territory in 1952-53. Clin. Features. Trans. R. Soc. Trop. Med. Hyg. 1955, 49(1):28-32.
26. Shiraki K., Daikoku T., Takemoto M., Yoshida Y., Suzuki K., Akahori Y., Okuno T., Kurosawa Y., Asano Y. Neutralizing anti-gH antibody of varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency. J. Virol. 2011, 85(16):8172-8180.
27. Sjöberg M., Garoff H. Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion. J. Virol. 2003, 77(6):3441-3450.
28. Simon F., Javelle E., Oliver M., Leparc-Goffart I., Marimoutou C. Chikungunya virus infection. Curr. Infect. Dis. Rep. 2011, 13(3):218-228.
29. Solignat M., Gay B., Higgs S., Briant L., Devaux C. Replication cycle of chikungunya: a re-emerging arbovirus. Virology 2009, 393(2):183-197.
30. Soonsawad P., Xing L., Milla E., Espinoza J.M., Kawano M., Marko M., Hsieh C., Furukawa H., Kawasaki M., Weerachatyanukul W., Srivastava R., Barnett S.W., Srivastava I.K., Cheng R.H. Structural evidence of glycoprotein assembly in cellular membrane compartments prior to alphavirus budding. J. Virol. 2010, 84(21):11145-11151.
31. Strauss J.H., Strauss E.G. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 1994, 58(3):491-562. (Review. Erratum. Microbiol. Rev. 1994, 58(4), 806.).
32. Treanor J.J., Tierney E.L., Zebedee S.L., Lamb R.A., Murphy B.R. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J. Virol. 1990, 64(3):1375-1377.
33. Warter L., Lee C.Y., Thiagarajan R., Grandadam M., Lebecque S., Lin R.T., Bertin-Maghit S., Ng L.F., Abastado J.P., Desprès P., Wang C.I., Nardin A Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J. Immunol. 2011, 186(5):3258-3264.
34. Weaver S.C., Osorio J.E., Livengood J.A., Chen R., Stinchcomb D.T. Chikungunya virus and prospects for a vaccine. Expert Rev. Vaccines 2012, 11(9):1087-1101.
35. Zheng Y., Sánchez-San Martín C., Qin Z.L., Kielian M. The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein. J. Virol. 2011, 85(13):6334-6342.